🇺🇸 FDA
Patent

US 12065404

C4-carboxylic acid-substituted tryptamine derivatives and methods of using

granted A61KA61K31/4045A61P

Quick answer

US patent 12065404 (C4-carboxylic acid-substituted tryptamine derivatives and methods of using) held by Enveric Biosciences Canada Inc. expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Enveric Biosciences Canada Inc.
Grant date
Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/4045, A61P, A61P25/00